Renal Dysfunction in a Patient With Crohn's Disease During Ustekinumab Treatment: A Case Report and Review of the Literature
ABSTRACT: Ustekinumab is a first-line drug for Crohn's disease. However, little is known about its potential adverse effects on renal function. We present the case of a 42-year-old man with Crohn's disease who developed chronic renal dysfunction during ustekinumab treatment, which resolved...
Saved in:
| Main Authors: | Yuge Wei, Ms, Gechong Ruan, MD, Yan Qin, MD, Xiaoyin Bai, MD, Hong Yang, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Current Therapeutic Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X24000237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
by: Manrong He, et al.
Published: (2021-12-01) -
Osteonecrosis of the jaw associated with ustekinumab in the treatment of Crohn's disease
by: Jean Massaad, et al.
Published: (2024-10-01) -
IgA Vasculitis Induced by Ustekinumab During Treatment for Crohn’s Disease: A Case Report
by: Yu Okada, et al.
Published: (2025-08-01) -
Short-Term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Real-World Retrospective Multicenter Study in China
by: Zhu X, et al.
Published: (2025-05-01) -
New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01)